Researchers conducted a study to assess the safety and efficacy of aminoglycosides or polymyxin monotherapy for the treatment of adults with complicated urinary tract infections caused by extensively drug-resistant Pseudomonas aeruginosa.
Prescribers need to weigh the clinical benefits and potential cardiac risks of respiratory fluoroquinolones and amoxicillin-based antibiotics on an individual basis.
Investigators conducted a cohort study that compared adverse effects and outcomes among patients with community-acquired urinary tract infection treated with cotrimoxazole vs fluoroquinolones.
The American College of Physicians convened a panel to identify best practices for the use of short-course antibiotics in the management of common infections.
Findings support prescribing antimicrobials for no longer than needed.
Proton pump inhibitors, beta-blockers, antimetabolites linked to infection with antibiotic-resistant bacteria
Best practices recommend limiting antibiotics to 5 days for COPD exacerbations, acute uncomplicated bronchitis
